Try our Advanced Search for more refined results
United States of America et al v. RS Compounding LLC et al
Case Number:
8:13-cv-03150
Court:
Nature of Suit:
Judge:
Firms
-
September 28, 2018
Compounding Pharmacy, Owner Ink $1.2M Deal In FCA Case
The federal government said Friday that a Florida compounding pharmacy and its owner have agreed to a $1.2 million deal to end a False Claims Act suit alleging they overbilled the government's Tricare program.
-
January 11, 2018
Fla. Compounding Pharmacy, Execs Escape Rep's FCA Claims
A federal judge on Wednesday threw out a former sales representative's amended False Claims Act suit against a Florida compounding pharmacy and its top executives, finding her pleadings insufficient on claims outside of an accusation of overbilling the government's Tricare program on which the government has already intervened.
-
December 04, 2017
Fla. Compounding Pharmacy Can't Escape Tricare FCA Suit
A Florida federal judge refused Monday to dismiss the federal government's False Claims Act suit against a compounding pharmacy accused of overbilling Tricare for prescriptions, saying the government had sufficiently backed its allegations against both the company and its owner.
-
November 09, 2017
Fla. Compounding Pharmacy Ducks Whistleblower's FCA Suit
A federal judge tossed a False Claims Act suit accusing a Florida compounding pharmacy of overcharging Tricare, Medicare and Medicaid for certain treatments, finding Wednesday the whistleblower who brought the suit hadn't been privy to the inside information needed to support her case.
-
September 25, 2017
16 States Won't Intervene In FCA Suit Against Compounder
Sixteen states declined Monday to intervene in a whistleblower False Claims Act suit accusing a Florida compounding pharmacy of charging Tricare, Medicare and Medicaid excessively high rates for certain compounded drugs, after the federal government previously intervened in the suit.
-
July 03, 2017
Fla. Compounding Pharmacy Ripped Off Tricare, Feds Claim
A compounding pharmacy based in Tampa, Florida, charged Tricare at least 2,000 percent more for drugs than it charged cash payers in violation of the False Claims Act, the federal government said as it intervened in a whistleblower’s suit.